NEW YORK (GenomeWeb) – Signal Genetics said before the opening of the market that its first quarter revenues increased 27 percent year over year.

For the three months ended March 31, the Carlsbad, California-based molecular diagnostics firm reported revenue of $818,000, up from $645,000 a year ago, attributable to a record number of tests billed for clinical patients, the firm said in a statement.

The number of tests billed for increased 93 percent year over year, due to increased commercial presence, the firm said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.